恶性疟原虫K13表达与青蒿素联合疗法寄生虫清除相关
该研究纳入47例坦桑尼亚儿童无并发症恶性疟疾患者,住院接受蒿甲醚-苯芴醇治疗。通过实时PCR检测治疗前后多个时间点pfk13转录水平,发现pfk13转录下调与寄生虫清除时间延长呈负相关,提示PfK13转录反应降低可能是青蒿素耐受/耐药的第一步。
要点
- pfk13转录水平在治疗后各时间点存在广泛变异。
- pfk13下调与更长的寄生虫清除时间相关。
- 降低的PfK13转录反应可能提示青蒿素耐受/耐药早期。
核心结论
- pfk13转录下调与蒿甲醚-苯芴醇治疗后寄生虫清除时间延长呈负相关。
- 降低的PfK13转录反应可能代表青蒿素耐受/耐药的第一步。
研究设计与样本
- 研究为临床试验(ID: NCT00336375),纳入47例经显微镜确诊的坦桑尼亚无并发症恶性疟疾儿童。
- 患者住院接受蒿甲醚-苯芴醇治疗,在治疗前及治疗后五个时间点采集静脉血。
- 提取RNA合成cDNA,通过实时PCR测量pfk13转录本。
主要发现
- 在蒿甲醚-苯芴醇治疗后所有时间点均观察到广泛的pfk13转录本变异。
- 结合寄生虫清除数据与pfk13转录谱,发现pfk13下调与更长的寄生虫清除时间相关。
临床怎么用
- 在临床中监测pfk13转录水平可能有助于早期识别青蒿素耐受/耐药风险。
- 对于疟疾患者,若pfk13转录反应降低,需警惕寄生虫清除延迟。
局限性
- 样本量较小(47例儿童),需更大规模研究验证。
- 研究未发现非洲地区显著延长的清除时间,且当前寄生虫清除变异不能由K13多态性解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Delayed parasite clearance and, consequently, reduced efficacy of artemisinin-based combination therapies have been linked with Plasmodium falciparum K13 gene SNPs in Southeast Asia. In Africa, significantly prolonged clearance has not yet been observed and the presently restricted variation in parasite clearance cannot be explained by K13 polymorphisms. OBJECTIVES: Our aim was to study the in vivo pfK13 transcriptional response in patients treated with artemether-lumefantrine and explore whether the pfk13 transcripts can explain the patients' parasite clearance outcomes. PATIENTS AND METHODS: A total of 47 Tanzanian children with microscopically confirmed uncomplicated P. falciparum malaria were hospitalized and received artemether-lumefantrine treatment (clinical trial ID: NCT00336375). RNA was extracted from venous blood samples collected before treatment initiation and at five more timepoints after treatment. cDNA was synthesized and pfk13 transcripts measured by real-time PCR. RESULTS: A wide range of pfk13 transcript variation was observed throughout all timepoints after artemether-lumefantrine treatment. Taking parasite clearance data together with the pfk13 transcripts profile, we observed a negative correlation inferring that pfk13 down-regulation is associated with longer parasite clearance time. CONCLUSIONS: The findings suggest that a reduced PfK13 transcriptional response may represent a first step towards artemisinin tolerance/resistance.
引用
- Silva M, Ferreira PE, Otienoburu SD, et al. Plasmodium falciparum K13 expression associated with parasite clearance during artemisinin-based combination therapy. J Antimicrob Chemother. 2019. PMID: 30869127. doi:10.1093/jac/dkz098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。